On September 6, 2026, the highly anticipated 26th Asia-Pacific Association for Gynecologic Endoscopy (APAGE) Annual Congress & the 13th Indonesian Gynecological Endoscopy Society (IGES) 2026, officially commenced in Bali, Indonesia. Under the theme "Collective Brilliance: Elevating Gynecology Endoscopy through Shared Innovation," the congress brings together top experts in gynecologic minimally invasive surgery from the Asia-Pacific region and across the globe. Discussions will delve into hot topics such as cutting-edge gynecologic endoscopic techniques, AI applications, oncology diagnosis and treatment, fertility preservation, and robotic telesurgery. As the Official Exclusive Media Partner of the congress, OBGYN.net has dispatched a reporting team to the scene to provide real-time, first-hand updates on the latest academic trends.

Where emerald seas gather the finest minds, the frontier of surgical research comes alive. On September 4–5, 2026, the APAGE 2026 & 13th IGES flagship academic program — twelve specialized hands-on technique workshops — successfully concluded on the Indonesian island of Bali. As the core academic segment of the congress, distinguished by its strong practical value, this edition focused on advancing clinical skills in gynecologic minimally invasive surgery and fostering international academic exchange. It brought together experts, frontline physicians, and nursing leaders from over twenty countries and regions, building a high-level Asia-Pacific training and exchange platform for minimally invasive techniques through immersive practice, refined instruction, and in-depth transnational discussion. The Obstetrics & Gynecology Network traveled to the venue to witness this international academic gathering firsthand and document the latest achievements in minimally invasive techniques. A Practice-Oriented, Problem-Solving Curriculum Unlike traditional academic meetings that emphasize theoretical presentations, this Workshop series was built around four core principles: practice-focused, difficulty-targeting, application-driven, and exchange-oriented. Moving beyond generic academic lectures, it established twelve vertical, segmented training tracks centered on the challenging pain points and procedural blind spots of clinical gynecologic minimally invasive surgery... Breaking Barriers, Sharing Across Borders The core value of this international training workshop lay in breaking down the geographical barriers separating obstetric and gynecologic care across nations, achieving the interconnection, shared progress, and mutual learning of minimally invasive techniques throughout the Asia-Pacific region... Bridging China and the World Clinicians from multiple countries exchanged ideas and engaged in deep dialogue on the same stage... Several Chinese obstetric and gynecologic experts took the stage to share the clinical practice achievements and innovative techniques of Chinese minimally invasive gynecology, conveying the strength of Chinese obstetric and gynecologic medicine to the Asia-Pacific medical community... A Successful Conclusion, A Lasting Mission The two-day hands-on workshop came to a successful close... reflecting the vibrant atmosphere of dedication and collaborative progress that characterizes the Asia-Pacific field of minimally invasive obstetrics and gynecology.

Advanced Hysteroscopy Hands-on Course

Recently, the inaugural congress of the International Society of Obstetrics‑Gynecology Ablation (ISOGA) concluded successfully in the Philippines, opening a brand‑new chapter for minimally‑invasive ablation diagnosis and treatment in global obstetrics and gynecology. Major good news emerged from the event: Professor Gong Xiaoming, chief expert at Woyi Minimally‑Non‑Invasive Medicine, has been appointed Chair of ISOGA. This appointment stands as high‑recognition from the international medical community for his years‑long dedication to gynecological minimally‑ and non‑invasive therapy. It also serves as vital proof that Chinese minimally‑invasive gynecological techniques have stepped onto the international forefront. His well‑deserved achievement rewards his long‑term devotion to this field.

The 3rd Annual Scientific Meeting of the Singapore Society of Gynecological Minimally Invasive Surgery (SGMIS) was successfully held in Singapore on July 24–25, 2026. As a high-profile academic event in the field of gynecological minimally invasive surgery, the meeting gathered global experts to share cutting-edge research results and clinical practical experiences.

A research team led by Professor Xiang Yang from Peking Union Medical College Hospital joined forces with Professor Sun Pengming’s team from Fujian Maternity and Child Health Hospital to publish a landmark research finding in a journal of the Nature portfolio. The study systematically elucidates the dichotomous oncogenic role of CD112, a novel immune checkpoint, in cervical cancer progression, which simultaneously mediates tumor immunosuppression and ferroptosis metabolic resistance. This finding breaks the inherent limitations of single-target immunotherapy for cervical cancer and delivers an innovative combinatorial target and translational theoretical foundation for overcoming PD-1 inhibitor resistance in patients with advanced cervical cancer in clinical practice.

the 14th OB/GYN Network Surgical Video Competition embarks on a new journey. Submission of entries is now open nationwide. We sincerely invite young and middle-aged physicians from all regions to submit entries, showcasing your superb surgical skills and sharing clinical experience with fellow practitioners.

Can I still get pregnant if fibroids or ovarian cysts are detected during pre-pregnancy planning? What are the risks associated with having a second or third child at an advanced maternal age? Is painless childbirth safe? What should men do to prepare for conception? Recently, the National Health Commission of China (NHCC) held a press conference themed "Promoting Reproductive Health." Several top medical experts were invited to provide professional answers to common public concerns regarding fertility, pregnancy, childbirth, and the postpartum period, while also sharing the latest progress in national reproductive health services across China.

From June 10 to 13 local time, the 51st Annual Meeting of the International Association of Gynecology and Urology (IUGA) grandly opened in Rio de Janeiro, Brazil. As the highest-level and most influential academic event in the global field of pelvic floor urogynecology, this year's conference innovatively features the Balloon Debate session, focusing on the "optimal treatment plan for recurrent anterior vaginal prolapse after hysterectomy." Multiple rounds of expert competitions will be held, using innovative interactive formats to spark diagnostic and treatment ideas, fully demonstrating an open and inclusive international academic atmosphere in the pelvic floor field, centered on patient benefit. It provides a new reference paradigm for domestic academic exchange in the pelvic floor.

On June 25, 2026, Merck announced that its PD-1 inhibitor pembrolizumab (brand name: Kreida ®) has received approval from China's National Medical Products Administration (NMPA) for the use of a well-validated test to evaluate the treatment of adult patients with platinum-resistant epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer who have previously received first- or second-line systemic therapy who have expressed PD-L1 (Composite Positive Score (CPS)≥1). The approval of this new indication is based on data from the Phase III clinical trial KEYNOTE-B96 (ENGOT-ov65).